InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MANHARD KIMBERLY, Directeur Exécutif. Insider active across 1 companies, notably Heron Therapeutics, INC.. Cumulatively, 10 filings have been published. The latest transaction was disclosed on 29 April 2022 — J. Regulator: SEC (Form 4). The full history is free.
Declarations10 total
€5,5011,504 shares@ €3.65760.0022% mcap13.6% of flow
Common Stock
SEC:0001209191-22-027232:0·
1,250 shares
Common Stock
SEC:0001209191-22-024519:0·
1,250 shares
Common Stock
SEC:0001209191-22-003358·
1,250 shares
Common Stock
SEC:0001209191-22-003358:0·
1,250 shares
Common Stock
SEC:0001209191-21-060547·
1,250 shares
Common Stock
SEC:0001209191-21-060547:0·
1,250 shares
Common Stock
SEC:0001209191-21-046786·
1,250 shares
Common Stock
SEC:0001209191-21-046786:0·
€17,5221,529 shares@ €11.45990.0072% mcap100.0% of flow
Common Stock
SEC:0001209191-21-030014·
€17,5221,529 shares@ €11.45990.0072% mcap43.2% of flow
Common Stock
SEC:0001209191-21-030014:0·
10 of 10 declarations
About MANHARD KIMBERLY
Kimberly Manhard is Executive Vice President, Drug Development at Heron Therapeutics, Inc., a biopharmaceutical company. She oversees drug development, playing a key role in innovation and research within the company.
